Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Planned sale · Filed 25/12/29

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Peter HeermaChief Commercial Officer
Planned sale date: 25/12/24
Filed: 25/12/29

More to sell after $275.5K in 3 months

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/24~01/23

Peter Heerma's recent trades

Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$525.7K
8,282 sh
$525.7K
Filed 09/17
Traded 09/17
Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$10.8M
172,717 sh
$10.8M
Filed 09/16
Traded 09/16
Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.7M
102,190 sh
$6.7M
Filed 09/15
Traded 09/15
Peter HeermaChief Commercial Officer
SellTravere Therapeutics
Sell
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
Peter HeermaChief Commercial Officer
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/05
Traded 05/05

Peter Heerma, Chief Officer — plans to sell 4,980 sh of Travere Therapeutics TVTX · $199.2K · around 12/24 · 10b5-1 plan | Whalegun